Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
-
Field
-
de linguagem (LLMs), agentes e sandbox)”, ref. Projeto Interno REACT-NET/I&D+i/IPLeiria/2026, financed by IPLeiria in the following terms: . SCIENTIFIC AREA: Computer Engineer. . RECIPIENTS: Holders
-
contributing to student led events, literary programming, or campus based initiatives. Experience contributing to digital content or promotional efforts (e.g., social media, newsletters, literary magazines
-
a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description The Molecular Oncology group (http://bit.ly/molonco ) at Institut de Recerca Biomèdica de
-
will be given to candidates with suitable scientific and professional curriculum such as: experience with social AI EVALUATION CRITERIA The selection will be based on the following criteria: Academic CV
-
promoting recyclability. To achieve this, the following tasks are proposed: 1. Development of polymer formulations incorporating active agents and/or biopolymers; 2. Production and optimization of films with
-
expertise in agent-based modelling. The models we build will have an interface with community stakeholders and mobility service providers, so we are particularly seeking applicants who are comfortable in
-
. Additional optional skills and qualifications: Experience in the development of software and agents for intelligent document processing. Contracting requirements: Presentation of the academic qualifications
-
. The fellowship is due to start in 04/2026. . WORK PLAN: Development and characterization (physicochemical, mechanical and biological) of 3D biphasic structures based on electrospinning with bioactive agents
-
UiO/Anders Lien 19th April 2026 Languages English English English PhD Research Fellow in Control and Optimization for Multi-Agent UAV Systems Apply for this job See advertisement About the position
-
Medicine, Division of Cardiovascular Health & Disease is recruiting a full-time Post Doctoral Fellow to work with Dr. Christy Holland and Dr. Kevin Haworth to develop targeted echogenic agents with